Vivani Medical, Inc.
Vivani Medical, Inc. (Nasdaq: VANI) is a clinical-stage biopharmaceutical company developing miniature, long-acting subdermal drug implants using its proprietary NanoPortal technology, designed to provide sustained drug delivery for chronic diseases while allowing the implant to be removed. Its programs focus… From the company’s description.
In fiscal 2025, Vivani Medical, Inc. reported a net loss of $26.61M. Operations used $24.32M in cash.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Vivani Medical, Inc. does
In the company’s own words
Vivani Medical, Inc. (Nasdaq: VANI) is a clinical-stage biopharmaceutical company developing miniature, long-acting subdermal drug implants using its proprietary NanoPortal technology, designed to provide sustained drug delivery for chronic diseases while allowing the implant to be removed. Its programs focus primarily on GLP-1 medicines: NPM-139 and NPM-133 are semaglutide implants in development for chronic weight management and type 2 diabetes, respectively, while NPM-115 is an exenatide implant for weight management. OKV-119, an exenatide implant for companion cats and dogs, is being developed with Okava Pharmaceuticals, which is responsible for its clinical development, regulatory activities and potential commercialization. Vivani also owns Cortigent, which holds neurostimulation assets from legacy company Second Sight and is being considered for separation from Vivani. The company resulted from the 2022 combination of Second Sight and Nano Precision Medical, and its current priority is drug-implant development. Vivani reported no products approved for commercial sale and completed its first-in-human study of NPM-115 in 2025. Its website is www.vivani.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Electromedical Apparatus
- Headquarters
- ALAMEDA, CA
- Fiscal year end
- December
- CIK
- 1266806
- SIC
- 3845
Financial performance, year by year
Fiscal 2015–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Vivani Medical, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Vivani Medical, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Vivani Medical, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Vivani Medical, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Vivani Medical, Inc.'s last four quarterly filings that the numbers alone won't show?”